Figure 14.
Manufacturing capacity by end of 2021 of lead companies producing COVID-19 vaccines. (Vaccine courses are assumed to require two doses) [399].
Manufacturing capacity by end of 2021 of lead companies producing COVID-19 vaccines. (Vaccine courses are assumed to require two doses) [399].